By: Kairos Ventures On: March 21, 2023 In: Portfolio News, PteroDynamics

PteroDynamics announced the appointment of Richard Brasel as its Chief Revenue Officer. Brasel brings with him a wealth of...

Read more
By: Kairos Ventures On: February 28, 2023 In: Portfolio News, PteroDynamics

PteroDynamics announced the close of a $7.5 million Seed round. The round was co-led by existing investor Kairos Ventures...

Read more

Tempus announced a brand-new multi-omics collaboration with Actuate Therapeutics to support its ongoing Phase 1/2 Study of elraglusib, formerly...

Read more

Becky Schultz speaks with founder and CEO of Transient Plasma Systems, Dan Singleton, about the company’s plasma-based aftertreatment and...

Read more
By: Kairos Ventures On: January 19, 2023 In: Linnaeus, Portfolio News

Linnaeus Therapeutics announced that the FDA has granted orphan drug designation for LNS8801 for the treatment of patients with...

Read more
By: Kairos Ventures On: January 18, 2023 In: MemVerge, Portfolio News

MemVerge announced that Jeffrey Wang has been named Vice President of Engineering. With decades of software-defined infrastructure experience across...

Read more
By: Kairos Ventures On: January 11, 2023 In: Applaud Medical, Portfolio News

Applaud Medical announced the appointment of industry veteran Paul Molloy as CEO. The company has also added Molloy to...

Read more
By: Kairos Ventures On: January 10, 2023 In: MemVerge, Portfolio News

MemVerge Memory Machine™ is the first software-defined Compute Express Linkä (CXLä) memory management solution to offer support for the...

Read more

A new trial sponsored by Axial Therapeutics will test whether a medication that targets gut bacteria can also improve...

Read more
By: Kairos Ventures On: December 5, 2022 In: Portfolio News, Vivodyne

Vivodyne announced today that it has expanded its executive team with Dr. Susan Billings joining as its Chief Commercial...

Read more